Information Regarding Revolade
Dear Oxleas NHS Foundation Trust,
I would like to request information for the below questions.
The purpose of these questions is to understand the variability of treatment within your trust and in context to the rest of the country.
Q1. How many patients has your trust treated (for any disease) in the last 6 months (or the latest 6 months data you have available) with the following treatments:
• Revolade (eltrombopag)
• Nplate (romiplostim)
• Doptelet (avatrombopag)
• Tavlesse (fostamatinib)
Q2. In the last 6 months (or the latest 6 months data you have available), how many patients has your trust treated for immune thrombocytopenia (ITP)?
Q3. Of the patients treated for immune thrombocytopenia (ITP) in the last 6 months (or the latest 6 months data you have available), how many were treated with:
rituximab
mycophenolate mofetil
surgery (splenectomy)
Q4. Does your trust participate in any ongoing clinical trials for immune thrombocytopenia (ITP)? If so, can you please provide the name of each trial along with the number of patients taking part?
Thank you for taking the time to answer these questions and I look forward to your response.
Yours faithfully,
Oliver Caswell
Dear Oliver,
FREEDOM OF INFORMATION ACT 2000 – SECTION 8 REQUEST
Thank you for your request for information dated 31/03/2022. Your request
has been managed under the terms of the Freedom of Information Act 2000.
You requested the following information under section 8 of the Act:
Q1. How many patients has your trust treated (for any disease) in the last
6 months (or the latest 6 months data you have available) with the
following treatments:
• Revolade (eltrombopag)
• Nplate (romiplostim)
• Doptelet (avatrombopag)
• Tavlesse (fostamatinib)
Q2. In the last 6 months (or the latest 6 months data you have available),
how many patients has your trust treated for immune thrombocytopenia
(ITP)?
Q3. Of the patients treated for immune thrombocytopenia (ITP) in the last
6 months (or the latest 6 months data you have available), how many were
treated with:
• rituximab
• mycophenolate mofetil
• surgery (splenectomy)
Q4. Does your trust participate in any ongoing clinical trials for immune
thrombocytopenia (ITP)? If so, can you please provide the name of each
trial along with the number of patients taking part?
Our response to your request is:
The information you have requested is not held by the Trust.
Please note that Oxleas NHS Foundation Trust do not run acute hospitals
but are a community NHS Trust and mental health service provider. For more
information on services provided by Oxleas NHS Foundation Trust please
visit our website at [1]http://oxleas.nhs.uk/services/.
Following this response, your request for information will be closed.
If you have any queries or concerns or are dissatisfied with the service
you have received in relation to your request, please do not hesitate to
contact us. If you wish to make request a review of the decision, you
should write to the: Information Governance Manager, Julie Lucas via email
at [2][email address] in the first instance. If you remain
unsatisfied with the outcome of your review and wish to make a formal
complaint please address this to the Head of Complaints, Oxleas NHS
Foundation Trust, Pinewood House, Pinewood Place, Dartford DA2 7WG -
Email: [3][email address]
In addition if you are not satisfied with the outcome of your complaint or
review, you may apply directly to the Information Commissioner’s Office
(ICO) for a decision. Generally, the ICO cannot make a decision unless you
have exhausted the complaints procedure provided by the Trust. The ICO can
be contacted at: Information Commissioner's Office, Wycliffe House, Water
Lane, Wilmslow, Cheshire, SK9 5AF (Telephone: 0303 123 1113 or 01625 545
745 - [4]www.ico.org.uk).
Kind regards,
Paul Bransgrove
Information Governance Officer
E: [5][Oxleas NHS Foundation Trust request email]
Oxleas NHS Foundation Trust | Bracken House | Bracton Lane | Leyton Cross
Road | Dartford | Kent | DA2 7AF
══════════════════════════════════════════════════════════════════════════
From: Oliver Caswell <[FOI #849525 email]>
Sent: 31 March 2022 15:31
To: FOI (OXLEAS NHS FOUNDATION TRUST) <[email address]>
Subject: Freedom of Information request - Information Regarding Revolade
Dear Oxleas NHS Foundation Trust,
I would like to request information for the below questions.
The purpose of these questions is to understand the variability of
treatment within your trust and in context to the rest of the country.
Q1. How many patients has your trust treated (for any disease) in the last
6 months (or the latest 6 months data you have available) with the
following treatments:
• Revolade (eltrombopag)
• Nplate (romiplostim)
• Doptelet (avatrombopag)
• Tavlesse (fostamatinib)
Q2. In the last 6 months (or the latest 6 months data you have available),
how many patients has your trust treated for immune thrombocytopenia
(ITP)?
Q3. Of the patients treated for immune thrombocytopenia (ITP) in the last
6 months (or the latest 6 months data you have available), how many were
treated with:
rituximab
mycophenolate mofetil
surgery (splenectomy)
Q4. Does your trust participate in any ongoing clinical trials for immune
thrombocytopenia (ITP)? If so, can you please provide the name of each
trial along with the number of patients taking part?
Thank you for taking the time to answer these questions and I look forward
to your response.
Yours faithfully,
Oliver Caswell
-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #849525 email]
Is [Oxleas NHS Foundation Trust request email] the wrong address for Freedom of Information
requests to Oxleas NHS Foundation Trust? If so, please contact us using
this form:
[6]https://www.whatdotheyknow.com/change_re...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[7]https://www.whatdotheyknow.com/help/offi...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
[8]https://www.whatdotheyknow.com/help/ico-...
Please note that in some cases publication of requests and responses will
be delayed.
If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now